Dr Chrystalla Charalambous

As a commercially sharp, results-driven executive with over 17 years of leadership experience in the pharmaceutical and healthcare sectors, I bring a rare combination of strategic thinking, operational execution, and international business development expertise. I’ve led cross-functional teams, driven P&L growth in Cyprus and Malta, negotiated market access in complex regulatory environments, and launched major therapies in highly competitive fields.

I’m most valuable as an advisor or board member to:

Healthtech startups scaling across regulated markets

Pharmaceutical or medical device companies seeking access to Europe or navigating market entry, pricing and reimbursement challenges

Private equity or investor-backed ventures looking to commercialize medical innovation in emerging or developed markets

Purpose-driven organizations committed to diversity, inclusion, and ethical growth

What makes me effective:

I’ve successfully led growth initiatives from startups to global pharma, including launch strategies, distributor networks, and tender negotiations.

I understand both science and strategy — holding a PhD in Molecular Genetics and an MBA, and have worked from medical advisory roles up to country leadership.

I’ve worked extensively with boards, regulatory bodies, and policy groups, including KEFEA and ICC Women Cyprus, helping shape healthcare policy and business inclusion strategy.

My style is decisive, collaborative, and grounded in execution — I thrive when advising on growth strategy, market access, pricing, organizational transformation, and leadership alignment.